Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$1.76 USD
+0.06 (3.53%)
Updated May 14, 2024 04:00 PM ET
After-Market: $1.78 +0.02 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -2.03 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.58 |
Next Year | -5.58 |
EPS (TTM) | -8.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.33M | 15.42M | 76.98M | 106.22M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 14.36M | 15.90M | 88.86M | 134.64M |
Low Estimate | 14.30M | 14.94M | 65.10M | 77.80M |
Year ago Sales | 12.43M | 17.39M | 84.51M | 76.98M |
Year over Year Growth Est. | 15.29% | -11.33% | -8.91% | 37.98% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.03 | -1.83 | -6.58 | -5.58 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -2.60 | -2.24 | -8.03 | -6.91 |
High Estimate | -1.46 | -1.42 | -5.12 | -4.24 |
Low Estimate | -2.60 | -2.24 | -8.03 | -6.91 |
Year ago EPS | -3.15 | -3.60 | -8.47 | -6.58 |
Year over Year Growth Est. | 35.56% | 49.17% | 22.31% | 15.20% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.03 | -1.83 | -6.58 | -5.58 |
7 Days Ago | -2.03 | -1.83 | -6.58 | -5.58 |
30 Days Ago | -2.03 | -1.83 | -6.58 | -5.58 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | -0.40 | 1.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.03 | -1.83 | -6.58 | -5.58 |
Zacks Consensus Estimate | -2.03 | -1.83 | -6.58 | -5.58 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | -0.94 | -3.60 | -3.15 | NA |
Estimate | NA | -3.53 | -3.90 | -2.85 | NA |
Difference | NA | 2.59 | 0.30 | -0.30 | 0.86 |
Surprise | NA | 73.37% | 7.69% | -10.53% | 23.51% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more